509 filings
Page 14 of 26
6-K
maa7r2il9fjw2 rlv
13 Dec 22
Current report (foreign)
11:46am
6-K
xar0jm 8ktnyaxa
12 Dec 22
MorphoSys Presents Updated Tafasitamab Results in Newly Diagnosed DLBCL Patients from Final firstMIND Analysis at ASH 2022
6:14am
6-K
2bmp0 2jjx4slhdjd
12 Dec 22
MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022
6:04am
6-K
wgo dr3gx4
6 Dec 22
Current report (foreign)
4:13pm
6-K
ks8vq x3rf
6 Dec 22
Current report (foreign)
10:10am
6-K
ngvo0xv1vrvkl2x
5 Dec 22
Current report (foreign)
10:26am
6-K
8eqzzcw44dwgcej
29 Nov 22
Current report (foreign)
7:56am
6-K
0z4gu6rsje
28 Nov 22
Current report (foreign)
10:39am
6-K
0x02zogu7yl3djcps hb
28 Nov 22
Current report (foreign)
10:32am
6-K
c39xcwoe0c9322nw 5h
28 Nov 22
Current report (foreign)
10:24am
6-K
duet3vwi 5v27
22 Nov 22
Current report (foreign)
11:20am
6-K
lug p12c7sc70
22 Nov 22
Current report (foreign)
11:14am
6-K
tp39pli4wifzjl6uqefe
21 Nov 22
Current report (foreign)
10:04am
6-K
u45pjsth
17 Nov 22
MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results
10:37am
6-K
ymqqpv
16 Nov 22
Third Quarter Interim Statement January – September
4:14pm
6-K
zkonop6u
16 Nov 22
Current report (foreign)
10:19am
6-K
0tp9h641vt76v2b
14 Nov 22
Conference Call Alert
6:44am
6-K
i96ejaiy0na30
14 Nov 22
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014
6:37am
6-K
oyktgry5x69bdzc
10 Nov 22
Current report (foreign)
10:25am
6-K
n0tq9s 1kvtfp
3 Nov 22
MorphoSys to Share New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) in 14 Presentations at the American Society of Hematology Annual Meeting
9:40am